Abstract 4344150: Perinatal PM2.5 Exposure Varies by Race and Ethnicity but Does Not Mediate Disparities in Infant Cardiac Surgery Outcomes: A Causal Mediation Analysis
Abstract
Introduction: Racial and ethnic disparities in congenital heart surgery outcomes are well documented and attributed to social determinants, but the full range of contributing factors remains unclear. Chronic exposure to particulate matter ≤2.5 µm diameter (PM2.5) is linked to adverse outcomes in adults. Given that minority communities are exposed to higher PM2.5 levels, we investigated how perinatal PM2.5 exposure mediates the relationship between race/ethnicity and infant congenital heart surgery outcomes. Hypothesis: Perinatal exposure to PM2.5 may be in the causal pathway between race/ethnicity and the days alive and out of healthcare (DAoH) among infants undergoing cardiac surgery (Image 1). Methods: We linked clinical registry data from the New York State (NYS) Congenital Heart Surgery Collaborative for Longitudinal Outcomes and Utilization of Resources with Medicaid claims and census tract-level daily PM2.5 concentrations from 2006-2017. Race/ethnicity was categorized as Hispanic, Non-Hispanic (NH) Asian, NH-Black, and NH-White. Our outcome was DAoH during the first two years of life (as % of 730 days). Mediator candidates included average exposure to PM2.5 during gestational weeks 0-8, 0-35, and postnatal period ages 0-1 and 0-2 years. We applied fractional logit and linear regression for each mediator, adjusting for clinical factors and surgical center, within a causal mediation framework. Analyses were then stratified by urbanicity. Results: Our cohort included 2,505 infants (33% Hispanic, 11% NH-Asian, 22% NH-Black, and 35% NH-White). Adjusted mean DAoH was 79.6% (95% CI 68.3-86.3) for Hispanic, 84.5% (70.3-87.3) for NH-Asian, 77.4% (66.6-86.4) for NH-Black, and 81.7% (70.0-86.3) for NH-White. In urban settings, NH-Black children experienced higher levels of PM2.5 (µg/m3) compared to NH-White children (0.44 µg/m3 [CI 0.25-0.64] at 0-35 gestational weeks, 0.44µg/m3[CI 0.27-0.61] age 0-1 year, and 0.32 µg/m3 [CI 0.16-0.48] age 0-2 years). PM2.5 exposure was not significantly associated with DAoH. Mediation analyses revealed no significant indirect effect. Conclusion: While differences in perinatal exposure to PM2.5 were observed by race/ethnicity among infants living in urban areas, our findings suggest that this environmental factor does not mediate racial and ethnic disparities in outcomes after congenital heart surgery in NYS. This highlights the need to explore other determinants of postoperative disparities in pediatric cardiac care.
Article Details
Authors (21)
Saranya Ramadurai
Mount Sinai Hospital, New York, New York, United States
Eric Zhou
Mount Sinai Hospital, New York, New York, United States
Sarah Crook
Mount Sinai Hospital, New York, New York, United States
Chantal Sanchez
Mount Sinai Hospital, New York, New York, United States
Andrew Goldstone
Columbia University Medical Center, New York, New York, United States
John Billings
New York University, New York, New York, United States
Jane Newburger
Department of Cardiology, Boston Children’s Hospital
Marshall Jacobs
Johns Hopkins Medical Institution, Baltimore, Maryland, United States
Rebecca Ebstein
Cornell Medical Center, New York, New York, United States
Alexandra Linder
CHILDRENS HOSPITAL BOSTON, Boston, Massachusetts, United States
Ralph Mosca
NYU Medical Center, New York, New York, United States
TK Kumar
NYU Langone Health, New York City, New York, United States
Neil Devejian
Albany Medical Center, Glenmont, New York, United States
Steven Kamenir
Albany Medical Center, Slingerlands, New York, United States
George Alfieris
University of Rochester, Rochester, New York, United States
Michael Swartz
UNIVERSITY OF ROCHESTER, Rochester, New York, United States
David Meyer
Northwell Medical Center, Uniondale, New York, United States
Joyce Woo
Nathan Graber
New York Department of Health, New York, New York, United States
Perry Sheffield
Mount Sinai Hospital, New York, New York, United States
Brett Anderson
Icahn School of Medicine, New York, New York, United States